Project Details
Description
Self-deliverable RNAi (sd-rxRNAi) to Enhance T-cell Therapies in a Pre-clinical AML Model
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/17 → 11/30/19 |
Funding
- RXI PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.